Vaccine Increases Disease-Free Survival for Follicular Lymphoma Patients
| MD Anderson Cancer CenterVaccine Increases Disease-Free Survival for Follicular Lymphoma Patients | MD Anderson Cancer Center

Vaccine Increases Disease-Free Survival for Follicular Lymphoma Patients. MD Anderson News Release 05/31/2011 ... A lymphoma vaccine uniquely tailored for each patient extends disease-free survival by 14 months, with signs of an even better ... extending disease-free survival time from 28.7 months to 52.9 months. While those results need to be confirmed in randomized ... "Survival of follicular lymphoma patients has improved with newer types of chemotherapy, but advanced-stage disease still is ...
more infohttps://www.mdanderson.org/newsroom/2011/05/vaccine-increases-disease-free-survival-for-follicular-lymphoma-.html

BRAFV600E Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer | SpringerLinkBRAFV600E Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer | SpringerLink

22 %, p , 0.001). Five-year disease-free survival was 89.6 % for BRAFV600E positive and 96.3 % for negative tumours, p , 0.001 ... The primary outcome measure was disease-free survival. Secondary outcome measures were tumour size, nodal positivity and ... BRAFV600E Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer. ... extra-thyroidal extension and reduced disease-free survival. It is an additional useful prognostic biomarker. ...
more infohttps://link.springer.com/article/10.1007/s00268-016-3534-x

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancerZoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

... drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free survival ... Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer. *Download PDF Copy ... Disease-free survival was significantly improved in patients randomized to zoledronic acid plus letrozole compared to those ... giving a 5-year disease-free survival (DFS) probability of 0.93. There were 58 events in patients treated with tamoxifen and 44 ...
more infohttps://www.news-medical.net/news/20181022/Zoledronic-acid-increases-disease-free-survival-in-premenopausal-women-with-HR2b-early-breast-cancer.aspx

Denosumab improves disease-free survival for postmenopausal patients w HR+ breast cancer | EurekAlert! Science NewsDenosumab improves disease-free survival for postmenopausal patients w HR+ breast cancer | EurekAlert! Science News

Adding denosumab to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal patients with early- ... Denosumab improves disease-free survival for postmenopausal patients w HR+ breast cancer Previous results from ABCSG-18 showed ... Denosumab improves disease-free survival for postmenopausal patients w HR+ breast cancer. American Association for Cancer ... Title: The Impact of Adjuvant Denosumab on Disease-Free Survival: Results from 3,425 Postmenopausal Patients of the ABCSG-18 ...
more infohttps://www.eurekalert.org/pub_releases/2015-12/aafc-did120415.php

HPV Status Linked to Overall and Disease-Free Survival in Vulvar CancerHPV Status Linked to Overall and Disease-Free Survival in Vulvar Cancer

The researchers examined overall survival, disease-free survival, disease-specific survival and progression-free survival.. The ... In addition, disease-free, disease-specific and progression-free survival pointed toward more favorable outcomes among women ... HPV Status Linked to Overall and Disease-Free Survival in Vulvar Cancer. Women with vulvar cancer who test positive for human ... publications/cure/2018/womens-cancers-2018/hpv-status-linked-to-overall-and-diseasefree-survival-in-vulvar-cancer ...
more infohttps://www.curetoday.com/publications/cure/2018/womens-cancers-2018/hpv-status-linked-to-overall-and-diseasefree-survival-in-vulvar-cancer

topic:Disease-Free Survival found 772 records • Arctic Healthtopic:"Disease-Free Survival" found 772 records • Arctic Health

Disease-Free Survival Dose Fractionation Female Hodgkin Disease - radiotherapy Humans Incidence Kaplan-Meier Estimate ... Acute Disease Adolescent Adult Disease-Free Survival Estonia - epidemiology Female Hematopoietic Stem Cell Transplantation ... Disease-Free Survival Female Finland Graft Rejection Graft Survival Hematopoietic Stem Cell Transplantation - adverse effects ... Acute Disease Age Distribution Child Child, Preschool Disease-Free Survival Down Syndrome - complications - epidemiology - ...
more infohttps://arctichealth.org/en/list?q=topic%3A%22Disease-Free+Survival%22&p=1&ps=&sort=title_sort+asc

Disease-Free Survival after Hepatic Resection in Hepatocellular Carcinoma Patients: A Prediction Approach Using Artificial...Disease-Free Survival after Hepatic Resection in Hepatocellular Carcinoma Patients: A Prediction Approach Using Artificial...

From each of the three groups, 80% of the cases (342, 283 and 238 cases of 1-, 3- and 5-year disease-free survival, ... Data for 427, 354 and 297 HCC patients with histories of 1-, 3- and 5-year disease-free survival after hepatic resection, ... This study demonstrated the feasibility of using ANNs in medical decision support systems for predicting disease-free survival ... and 5-year disease-free survival based on a set of clinical parameters for this patient group. Methods The three prediction ...
more infohttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0029179

Obinutuzumab Prolongs Disease-Free Survival vs Rituximab in Follicular Lymphoma - The ASCO PostObinutuzumab Prolongs Disease-Free Survival vs Rituximab in Follicular Lymphoma - The ASCO Post

Median progression-free survival has not been reached in either arm, but the data suggest that progression-free survival will ... Obinutuzumab Prolongs Disease-Free Survival vs Rituximab in Follicular Lymphoma. By Alice Goodman. December 25, 2016. ... 1. Marcus RE, Davies AJ, Ando K, et al: Obinutuzumab-based induction and maintenance prolongs progression-free survival in ... The study met the primary endpoint of investigator-assessed progression-free survival by computed tomography scan criteria, ...
more infohttps://www.ascopost.com/issues/december-25-2016/obinutuzumab-prolongs-disease-free-survival-vs-rituximab-in-follicular-lymphoma/

Survival and disease-free survival by breast density and phenotype in interval breast cancers | Cancer Epidemiology, Biomarkers...Survival and disease-free survival by breast density and phenotype in interval breast cancers | Cancer Epidemiology, Biomarkers...

Survival and disease-free survival by breast density and phenotype in interval breast cancers. Maria Sala, Laia Domingo, Javier ... Survival and disease-free survival by breast density and phenotype in interval breast cancers ... Background:We aimed to evaluate survival and disease-free survival in different subtypes of interval cancers by breast density ... Survival and disease-free survival by breast density and phenotype in interval breast cancers ...
more infohttp://cebp.aacrjournals.org/content/early/2018/05/31/1055-9965.EPI-17-0995

Combination melanoma vaccine, IL-2 extends disease free cancer survival | EmaxHealthCombination melanoma vaccine, IL-2 extends disease free cancer survival | EmaxHealth

... progression-free survival was 2.2 months versus 6 percent and 1.6 months. ... All of the patients in the melanoma vaccine trial had advanced disease that had spread to other organs. ... Secondary endpoints included toxic effects of the treatment and survival without progression of melanoma. ...
more infohttps://www.emaxhealth.com/1020/combination-melanoma-vaccine-il-2-extends-disease-free-cancer-survival

Neratinib Improves Disease-Free Survival in Early-Stage  HER2-Positive Breast Cancer - The ASCO PostNeratinib Improves Disease-Free Survival in Early-Stage HER2-Positive Breast Cancer - The ASCO Post

Neratinib Improves Disease-Free Survival in Early-Stage HER2-Positive Breast Cancer. By Chase Doyle and Caroline Helwick. ... "ExteNET is the first study to show a statistically significant improvement in invasive disease-free survival in the intent-to- ... ExteNets primary analysis was the invasive disease-free survival for all patients treated who had completed 2 years of follow- ... 2. Chan A, Martin M, Von Minckwitz G, et al: Invasive disease-free survival benefit following neratinib as extended adjuvant ...
more infohttp://www.ascopost.com/issues/november-25-2015/neratinib-improves-disease-free-survival-in-early-stage-her2-positive-breast-cancer/

Smoking Linked to Shorter Disease-free Survival in Stage III Colon Cancer - The ASCO PostSmoking Linked to Shorter Disease-free Survival in Stage III Colon Cancer - The ASCO Post

... with significantly poorer disease-free survival observed for current vs never-smokers with BRAF wild-type disease (HR = 1.60, ... there was evidence of poorer disease-free survival for smokers vs nonsmokers with KRAS mutant disease. Among patients with KRAS ... Disease-free Survival in Ever-smokers. Median follow up in patients not experiencing events was 3.5 years. On unadjusted ... However, disease-free survival was significantly poorer for ever-smokers vs never-smokers who were male (HR = 1.33, 95% CI = ...
more infohttps://ascopost.com/issues/june-10-2013/smoking-linked-to-shorter-disease-free-survival-in-stage-iii-colon-cancer/

Virtual HDR CyberKnife SBRT for localized prostatic carcinoma: 5-Year disease-free survival and toxicity observations - AbstractVirtual HDR CyberKnife SBRT for localized prostatic carcinoma: 5-Year disease-free survival and toxicity observations - Abstract

... distant metastasis-free survival was 100 and 95% by risk-group, and disease-specific survival was 100%. Acute and late grade 2 ... CONCLUSION: Virtual HDR prostate SBRT creates a very low PSA nadir, a high rate of 5-year disease-free survival and an ... Virtual HDR CyberKnife SBRT for localized prostatic carcinoma: 5-Year disease-free survival and toxicity observations - ... biochemical-relapse-free survival was 100 and 92% for low-risk and intermediate-risk patients, respectively, by ASTRO ...
more infohttps://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/78241-virtual-hdr-cyberknife-sbrt-for-localized-prostatic-carcinoma-5-year-disease-free-survival-and-toxicity-observations-abstract.html

Antibody-Targeted Chemotherapy-Induced Remission and Stem Cell Transplantation Prolong Disease-Free Survival for Leukemia...Antibody-Targeted Chemotherapy-Induced Remission and Stem Cell Transplantation Prolong Disease-Free Survival for Leukemia...

... have prolonged disease-free survival following stem cell transplantation according to research presented today at the annual ... Antibody-Targeted Chemotherapy-Induced Remission and Stem Cell Transplantation Prolong Disease-Free Survival for Leukemia ... Antibody-Targeted Chemotherapy-Induced Remission and Stem Cell Transplantation Prolong Disease-Free Survival for Leukemia ... have prolonged disease-free survival following stem cell transplantation according to research presented today at the annual ...
more infohttps://www.fredhutch.org/en/news/releases/2000/12/ASH_Mylotarg.html

Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing...Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing...

A Phase II Randomized Trial Evaluating the Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast ... Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing ... to these patients may result in the elimination of HER2 expressing disseminated tumor cells and improved disease free survival. ... Breast Diseases. Skin Diseases. Paclitaxel. Docetaxel. Liposomal doxorubicin. Albumin-Bound Paclitaxel. Cyclophosphamide. ...
more infohttps://clinicaltrials.gov/ct2/show/NCT01779050

High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after...High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after...

... as well as to disease-free survival, 5-year rates of local failure and distant disease after preoperative radiochemotherapy and ... High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after ... Survivin expression may provide a novel predictive indicator for disease-free survival after preoperative radiochemotherapy and ... Low survivin expression was significantly related to an increased disease-free survival rate (77% vs 18% at 5 years in tumors ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed/12240548?dopt=Abstract

Renal-Cell Cancer Disease-Free Survival Up With Sunitinib | Physicians Weekly for Medical News, Journals & ArticlesRenal-Cell Cancer Disease-Free Survival Up With Sunitinib | Physician's Weekly for Medical News, Journals & Articles

Renal-Cell Cancer Disease-Free Survival Up With Sunitinib by Logan Thomison , Oct 11, 2016 , 0 comments ... The researchers found that the median duration of disease-free survival was 6.8 and 5.6 years in the sunitinib and placebo ... 11, 2016 (HealthDay News) - The duration of disease-free survival is increased with sunitinib treatment for patients with ... the median duration of disease-free survival was significantly longer in the sunitinib group than in the placebo group, at a ...
more infohttps://www.physiciansweekly.com/renal-cell-cancer-disease-free-survival-up-with-sunitinib/

DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year...DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year...

DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year ... Colorectal cancer DNA copy number alterations Comparative genomic hybridization (CGH) Gene expression alterations Disease-free ... histopathological parameters were assessed with the aim to identify molecular signatures associated with disease-free survival ... Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc ...
more infohttps://link.springer.com/article/10.1007%2Fs13402-016-0299-z

Disease-free survival was estimated using the Kaplan-Me | Open-iDisease-free survival was estimated using the Kaplan-Me | Open-i

Disease-free survival was estimated using the Kaplan-Meier method anddefined as the period between diagnosis and local or ... f01: Disease-free survival was estimated using the Kaplan-Meier method anddefined as the period between diagnosis and local or ... f01: Disease-free survival was estimated using the Kaplan-Meier method anddefined as the period between diagnosis and local or ... and its association with prognostic factors and disease-free survival. Martins DM, Vidal FC, Souza RD, Brusaca SA, Brito LM - ...
more infohttps://openi.nlm.nih.gov/detailedresult.php?img=PMC4230293_1414-431X-bjmbr-47-11-01008-gf001&req=4

Loss of P27Kip1 Expression Correlates with Tumor Grade and with Reduced Disease-free Survival in Primary Superficial Bladder...Loss of P27Kip1 Expression Correlates with Tumor Grade and with Reduced Disease-free Survival in Primary Superficial Bladder...

Kaplan-Meier curve for disease-free survival (A) and overall survival (B) in 96 patients who underwent surgery for primary ... On the other hand, tumor grade was significantly associated with disease-free survival (P = 0.01) but not overall survival (P ... The Kaplan-Meier curves of disease-free survival and overall survival within patients with low (,25% of cells) versus moderate ... and with disease-free survival (P = 0.0003 by log-rank test) and overall survival (P = 0.01 by log-rank test) in superficial ...
more infohttps://cancerres.aacrjournals.org/content/59/13/3245?ijkey=7f23e624ea46f83aa7ca8ca414db3391072a9e7d&keytype2=tf_ipsecsha

Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma | Clinical...Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma | Clinical...

Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma. Ernest Nadal ... Patients with increased miR-34b/c methylation had significantly shorter disease-free and overall survival as compared to ... Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma ... Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma ...
more infohttp://clincancerres.aacrjournals.org/content/early/2013/12/12/1078-0432.CCR-13-0736

Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival | Clinical Cancer...Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival | Clinical Cancer...

Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival. Jose M. Silva, ... Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival ... Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival ... Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival ...
more infohttp://clincancerres.aacrjournals.org/content/8/12/3761

Herceptin/Taxotere Combo Significantly Improves Disease-Free Survival for Women With Early HER2-Positive Breast Cancer | P&T...Herceptin/Taxotere Combo Significantly Improves Disease-Free Survival for Women With Early HER2-Positive Breast Cancer | P&T...

Herceptin/Taxotere Combo Significantly Improves Disease-Free Survival for Women With Early HER2-Positive Breast Cancer. ... a disease-free survival benefit was seen in the adjuvant setting with the addition of HERCEPTIN(R) to either of two TAXOTERE(R ... based regimens significantly improved disease free survival for women with early HER2-positive breast cancer. This data was ... Bone Marrow Transplant Survival Is Up Sharply Since Mid-2000s Despite older, sicker patients, mortality rate fell by a third in ...
more infohttps://www.ptcommunity.com/news/20051208/herceptintaxotere-combo-significantly-improves-disease-free-survival-women-early-her2

Predictors of Long-Term Disease-Free Survival After Resection of Hepatocellular Carcinoma: Two Decades of Experience at Chang...Predictors of Long-Term Disease-Free Survival After Resection of Hepatocellular Carcinoma: Two Decades of Experience at Chang...

... is a common disease in Taiwan. A high incidence of recurrence after hepatectomy is the most important cause of unsatisfactory ... Predictors Long-term disease-free survival Hepatic resection Hepatocellular carcinoma This is a preview of subscription content ... Predictors of Long-Term Disease-Free Survival After Resection of Hepatocellular Carcinoma: Two Decades of Experience at Chang ... lesions and an uneventful postoperative course are the two main independent predictors for long-term disease-free survival in ...
more infohttps://rd.springer.com/article/10.1245%2FASO.2003.09.012

Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous...Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous...

Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous ...
more infohttps://www.drugbank.ca/indications/DBCOND0118825